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Squamous dysplasia of the oral cavity indicates increased risk of progression to squamous cell carcinoma (SCC). An important
advance would be the development of a minimally invasive assay for identification of oral SCC and dysplasia. We have investigated
the suitability in this context of immunostaining oral smears for minichromosome maintainance proteins (MCMs), sensitive and
specific biomarkers of cell cycle entry. Immunohistochemical examination of 66 oral tissue samples showed a greater frequency of
Mcm-2 expression in surface layers of moderate/severe dysplasia and SCC compared to benign keratosis/mild dysplasia.
Immunocytochemistry for Mcm-2/Mcm-5 was performed on 101 oral smears. Conventional smears included 23 from normal
mucosa, benign proliferative disease and mild dysplasia, all of which were MCM negative. Of 52 conventional smears of SCC tissue
samples, 18 were inadequate. However, MCM-positive cells were present in 33/34 adequate samples. Of 26 liquid-based cytology
smears, 19 out of 20 smears from SCC were adequate and all were MCM positive. Six smears from benign lesions were adequate
and MCM negative. We conclude that MCMs are promising markers for early detection of oral SCC and dysplasia, particularly in a
liquid-based cytology platform. Detection of MCMs would be amenable to automation and potentially applicable in the developing
world. Further studies are now warranted.
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Oral squamous cell carcinoma (SCC) is the sixth most common
malignancy worldwide. Up to 500000 new cases of oral and
pharyngeal cancer are diagnosed annually and approximately 75%
of these occur in the developing world (Moore et al, 2000). The
most common precursor lesions are seen as white patches of the
oral mucosa, although only a minority of these will progress to
SCC. While frank SCCs can usually be identified readily on oral
examination, clinical differentiation of premalignant lesions and
early SCCs from benign proliferative conditions is difficult, in view
of the paucity of specific identifying features (Vokes et al, 1993).
It has been argued gross genomic aberrations may identify
lesions destined to progress to SCC (Lippman et al, 2005).
However, detecting such abnormalities requires specialist techni-
ques, for example image cytometry, that may not be universally
applicable. As an alternative, it has long been recognised that the
presence of dysplasia is associated with increased risk of
progression to SCC. Detection of dysplasia by biopsy and
histopathology requires trained surgeons and pathologists, leading
to underinvestigation in developing countries and overinvestiga-
tion and associated morbidity in developed countries. Moreover,
histological assessment of biopsies is subjective and prone to
inter- and intraobserver variation. An important advance would
be the development of a minimally invasive, objective test for the
identification of oral malignancy and dysplasia, based on
cytological sampling of the oral mucosa. Mucosal smears could
be performed by nonspecialists without significant morbidity and
would enable cost-effective testing that could conceivably be
applied to screening at risk populations.
Conventional cytological examination of exfoliated cells may
enable diagnosis of some cases of oral SCC but such techniques
have a high false positive rate (Dabelsteen et al, 1971). At present
there is considerable interest in exploiting improved under-
standing of the biology of cancer cells to develop biomarkers
capable of distinguishing malignant and dysplastic cells from their
normal counterparts. Importantly, any screening test based on
biomarkers could be amenable to automation, producing sub-
stantial cost savings and the potential for applications in the
developing world. In this regard, we are investigating the clinical
value of antibodies against minichromosome maintenance (MCM)
proteins in improving the detection of neoplastic cells in
cytological samples.
Minichromosome maintenance proteins 2–7 are essential for
eucaryotic DNA replication (Kearsey and Labib, 1998; Gonzalez
et al, 2005). All six proteins are abundant throughout the cell cycle
but are broken down rapidly on differentiation and more slowly in
quiescence (Kearsey et al, 1996; Maiorano et al, 1996; Musahl et al,
1998; Tanaka and Diffley, 2002; Gonzalez et al, 2005), making them
Received 20 December 2005; revised 20 February 2006; accepted 27
February 2006
*Correspondence: Dr N Coleman; E-mail: nc109@cam.ac.uk
5These two authors contributed equally to this work.
British Journal of Cancer (2006) 94, 1170–1175
& 2006 Cancer Research UK All rights reserved 0007– 0920/06 $30.00
www.bjcancer.com
M
o
l
e
c
u
l
a
r
D
i
a
g
n
o
s
t
i
c
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cycle. Antibodies against MCMs detect more cells in tissues than
other ‘proliferation’ markers such as Ki67 and proliferating cell
nuclear antigen (Freeman et al, 1999; Chatrath et al, 2003; Scott
et al, 2003). There is deregulated expression of MCMs 2–7 in
malignant/dysplastic epithelia, including in the surface cells
sampled in exfoliative cytology (Williams et al, 1998; Freeman
et al, 1999; Chatrath et al, 2003). We have previously exploited
these findings to develop tests for improved identification of
neoplastic cells from a number of anatomical sites, including
cervix, colon and larynx (Williams et al, 1998; Davies et al, 2002;
Chatrath et al, 2003).
In the present study, we have examined the potential utility of
MCMs as candidate biomarkers for detecting oral malignancy and
dysplasia in smears of oral lesions. We initially performed
immunohistochemical examination of 66 samples of oral mucosal
tissue, in which we observed striking differences in expression of
Mcm-2 in the surface layers of epithelium showing severe/
moderate dysplasia or SCC, compared to mildly dysplastic or
benign lesions. Based on this data we undertook MCM immuno-
cytochemistry of 101 oral smears. Taken together, our findings
suggest that immunocytochemical detection of MCMs can form the
basis of an effective minimally invasive screening test for oral
malignancy and dysplasia.
MATERIALS AND METHODS
Tissue samples
Blocks of paraffin-embedded, formalin-fixed oral biopsies were
obtained in accordance with Local Research Ethics Committee
approval. Histopathological diagnosis was made by consensus bet-
ween two and in many cases three histopathologists, using criteria
described in detail elsewhere (Odell and Morgan, 1998). The tissues
examined represented benign keratosis (n¼9); mild (n¼17),
moderate (n¼16) and severe (n¼14) dysplasia; and SCC (n¼10).
Immunohistochemistry
Sections (5mm) were cut onto aminopropyltriethoxysilane (APES)-
coated slides and processed for immunohistochemistry as
described previously (Freeman et al, 1999; Chatrath et al, 2003;
Scott et al, 2003). We used mouse monoclonal primary antibodies
against Mcm-2 (Mukherjee et al, 2001; Chatrath et al, 2003), Mcm-
5 (Mukherjee et al, 2001) and Ki67 (Mib-1 clone, DAKO, Ely, UK).
Briefly, primary antibody (100ml) was applied in a humidified
chamber at 41C overnight with gentle shaking in 1% BSA/TBS with
0.1% Triton X-100. The slides were then washed in TBS containing
0.025% Triton X-100 and incubated for 1h with biotinylated goat
anti-mouse secondary antibody (DAKO, Ely, UK). A streptavidin-
horseradish peroxidase system (DAKO, Ely, UK) with the substrate
diaminobenzidine was used to develop the stain. The slides were
then lightly counterstained with Harris’ haematoxylin, dehydrated
in increasing concentrations of alcohol and cleared in xylene.
Coverslips were applied with DEPEX mounting medium (Gurr,
BDH, Poole, Dorset, UK). Negative controls were performed for all
tissues by omitting the primary antibody. Sections of cervix
showing various grades of intraepithelial neoplasia were used as
positive controls (Freeman et al, 1999).
Quantification of antibody staining
For each marker, an indication of staining frequency was
determined by calculating a labelling index (LI), representing the
ratio of immunopositive to total epithelial cells assessed, counting
a minimum of 500 cells per case. Labelling indexes were
determined for the entire epithelium and, where epithelial
architecture was retained, for four epithelial compartments; the
superficial, middle and lower thirds of the epithelium and the basal
layer. For each section, the epithelial thirds were defined by
measuring the epithelial thickness and dividing by three. In the
SCCs, epithelial orientation is lost and we observed uniform
expression of the markers studied. A single LI was therefore
determined as a mean of five individual counts.
All counts were repeated by three observers (ISS, PC, RJD), and
an interobserver variation of less than 5% was seen. The final LI
values represented a mean of the LIs from the three observers. We
were particularly interested in the LI values for the superficial
epithelial third, as the cells in this layer are the ones most likely to
be sampled in oral smears.
Immunocytochemistry of oral smears
Oral smears were obtained from patients attending outpatient
clinics at Guy’s Hospital, London, with the approval of the Local
Research Ethics Committee. Smears were obtained using a blunt
rounded metal spatula. We examined 101 oral smears, 75 of which
were applied directly to glass slides in the conventional manner
and 26 of which were prepared as monolayers by liquid-based
cytology (LBC). The findings from subsequent histological
evaluation of the sampled epithelium were available in all cases.
The 75 conventional smears were prepared and stained as
described previously (Williams et al, 1998). While the majority of
samples were stained using a monoclonal antibody against Mcm-2
(65 cases), we also included 10 cases stained with a polyclonal
antibody against Mcm-5, as the distribution of Mcm-2 and Mcm-5
is essentially identical in tissues from a large number of anatomical
sites (Freeman et al, 1999). The 75 conventional smears included
23 from tissue shown by biopsy to represent normal mucosa
(n¼3); benign proliferative disease including lichen planus,
keratosis, pemphigoid and hairy leukoplakia (n¼17); and mild
dysplasia (n¼3). The remaining 52 conventional smears were
from fresh resection specimens for SCC.
For the 26 cases examined by LBC, the spatula was rinsed in
PreserveCyt solution (Cytyc Corporation, Boxborough, MA, USA).
The solution was then filtered through a TransCyt filter and the
cellular material deposited on a slide in a ThinPrep 2000
cytoprocessor according to the manufacturer’s protocols (Cytyc
Corporation, Boxborough, MA, USA) (Chatrath et al, 2003).
Immunocytochemical staining of the slides was performed on a
DAKO Universal Stainer (DAKO, Ely, Cambs, UK). The slides were
treated with 4mM sodium deoxycholate and washed in TBS. An
equal mixture of primary antibodies against Mcm-2 and Mcm-5
was used and the DAKO Chem Mate HRP-detection kit was
employed for all subsequent steps. The slides were counterstained
with a modified Papanicolaou method (Williams et al, 1998) on a
Leica Autostainer XL (Leica, Houston, TX, USA) and were then
mounted in DPX.
All test slides were scored by three observers (ISS, LSM, PC),
who were unaware of the clinico-pathological diagnosis and of
each other’s findings. A slide was considered adequate if epithelial
cells were present and was scored as positive if one or more MCM-
expressing epithelial cell was seen. There was no discrepancy in the
opinions of the three observers. Results were compared with the
histological diagnosis for the accompanying tissue samples.
Statistical analysis
Differences between Mcm-2 and Ki67 LIs were compared using the
Bland Altman limits of agreement analysis. Labelling index values
were compared using the Friedman test, and pairwise comparisons
were made using the Wilcoxon Signed Rank test. Differences in LIs
in the progression from normal oral mucosa through the various
grades of dysplasia to SCC were assessed using the Jonckheere–
Terpstra test. Analysis was carried out using SPSSv11 (SPSS inc,
Chicago).
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Tissue sections
In benign keratosis Mcm-2 and Ki67 were generally restricted to
basal proliferative compartments (Figure 1), similar to findings in
stratified squamous epithelia at other anatomical sites (Freeman
et al, 1999; Chatrath et al, 2003). In regions showing surface ortho-
and para-keratosis, expression of both markers also extended to
more superficial cells (Figure 2).
In dysplasia Mcm-2 and Ki67 were expressed at a higher
frequency in all layers of the epithelium (Figure 1). The Mcm-2 LIs
and Ki67 LIs showed similar patterns of variation between
samples, although the overall Mcm-2 LI values were consistently
higher than those for Ki67 (Figure 2). In the stages from keratosis
Mcm-2 Ki67
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Figure 1 Distribution of Mcm-2 and Ki67 in oral lesions. Immunohistochemical staining illustrating the distribution of Mcm-2 (left) and Ki67 (right) in
biopsies of oral mucosa showing benign keratosis and mild, moderate and severe dysplasia. All images are at  200 magnification.
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sthrough mild, then moderate to severe dysplasia, Mcm-2 was
expressed by increasing numbers of cells in all four epithelial
compartments analysed (Figure 2), but the most striking increase
was in the superficial layers (Po0.0001, Jonkheere–Terpstra test),
the source of cells most likely to be sampled in an oral smear. The
Mcm-2 LI for this layer (and, to a lesser extent, the Ki67 LI)
showed a distinct division between lesions showing benign
keratosis or mild dysplasia and those showing moderate or severe
dysplasia (Figure 2). Median Mcm-2 LI values were 9.2% for
benign keratosis and 21.6% for mild dysplasia, compared with
58.8% for moderate dysplasia and 77.7% for severe dysplasia.
There was a positive correlation between Mcm-2 LI and Ki67 LI
values in the superficial epithelial third for all samples combined
(Spearman’s r¼0.85, Po0.0001) (Figure 3), with the Mcm-2 LI
being significantly greater than the Ki67 LI in the superficial
epithelial third in severe (P¼0.001), moderate (P¼0.001) and
mild dysplasia (P¼0.004, Wilcoxon signed rank test) (Figure 2).
In SCC there was very widespread expression of Mcm-2 and
Ki67, with an overall Mcm-2 LI of 92% (range 80–98%). In
keeping with our findings at other anatomical sites (Freeman et al,
1999), the highest LI values were observed in the least
differentiated SCCs. Similarly high Mcm-2 LI values were seen in
the surface layers in all cases. Moreover, small clumps of sloughed
immunopositive epithelial cells were frequently identified at the
surface of SCCs, reminiscent of our findings in malignancies at
other sites (Davies et al, 2002).
14 14 15 16 16 17 99 N =
Severe dysplasia
Moderate dysplasia
Mild dysplasia
Keratosis
14 14 15 16 16 17 99 N =
Severe dysplasia
Moderate dysplasia
Mild dysplasia
Keratosis
14 14 15 16 16 17 99 N =
Severe dysplasia
Moderate dysplasia
Mild dysplasia
Keratosis
14 14 15 16 16 17 99 N =
Severe dysplasia
Moderate dysplasia
Mild dysplasia
Keratosis
120
100
80
60
40
20
0
–20
Marker
Mcm-2
Ki67
120
100
80
60
40
20
0
Marker
Mcm-2
Ki67
120
100
80
60
40
20
0
–20
120
100
80
60
40
20
0
–20
Marker
Mcm-2
Ki67
Marker
Mcm-2
Ki67
Superficial third  Middle third
Basal third Basal layer
A
C
B
D
Figure 2 Frequency of Mcm-2 and Ki67 expression in oral lesions. Box plots showing labelling indices for Mcm-2 and Ki67 in different compartments of
the oral epithelium in benign keratosis and in mild, moderate and severe dysplasia. Bars¼median; boxes¼IQR; whiskers¼range of data or 1.5 IQRs from
the end of the box; circles¼outliers; stars¼extreme outliers.
80.0
80.0 100.0
60.0
60.0
40.0
40.0
20.0
20.0
0.0
0.0
Mcm-2
K
i
6
7
Keratosis
Mild dysplasia
Moderate dysplasia
Severe dysplasia
Figure 3 Comparison of Mcm-2 and Ki67 labelling indices in the
superficial epithelial third of oral lesions. There is a positive correlation
between Mcm-2 and Ki67 LI values for the superficial third of the
epithelium in benign keratosis (n¼9), and in mild (n¼17), moderate
(n¼16) and severe (n¼17) dysplasia (r¼0.85; Po0.0001).
Approach to early detection of oral SCC
IS Scott et al
1173
British Journal of Cancer (2006) 94(8), 1170–1175 & 2006 Cancer Research UK
M
o
l
e
c
u
l
a
r
D
i
a
g
n
o
s
t
i
c
sOral smears
In view of the high frequency of Mcm-2 expression in the
superficial third of moderate and severe dysplasia and in the
surface layers of SCCs, a pilot study was undertaken to investigate
whether SCCs could be distinguished from mild dysplasia and
benign keratosis by immunocytochemical analysis of MCM
proteins in 101 smears of oral mucosa.
Of the 75 conventional smears examined, all samples taken from
the 23 cases of normal mucosa, benign proliferative disease and
mild dysplasia contained epithelial cells and were MCM negative
(Figure 4A). Of the 52 conventional smears taken from cases of
SCC, 18 proved inadequate for assessment, as they did not contain
epithelial cells. Of the 34 adequate smears, 33 contained MCM-
positive cells, which were readily identified, even at low
magnification (Figure 4B). In many cases, the counterstain enabled
cytological features of malignancy to be confirmed in the
immunopositive cells. Morphologically normal cells were MCM
negative. The one MCM-negative adequate smear from a SCC
represented a case of recurrent malignancy following radiotherapy,
where the biopsy showed stromal scarring and no malignant cells
appeared to have been sampled in the smear.
Of the 26 smears examined by LBC, 20 were from SCC. Only one
of these cases proved inadequate for assessment. MCM-positive
cells were present in all 19 of the adequate samples. Moreover, all
six LBC preparations from patients with benign lesions were
adequate and MCM negative. The LBC samples also produced
greater consistency of staining and ease of interpretation
compared to the conventional smears.
DISCUSSION
Numerous features of oral cancer make it well suited to early
detection through screening, subject to the availability of a suitable
and reliable test. Oral cancer is one of the most common malignant
lesions of the head and neck, particularly in developing countries,
where large populations are exposed to irritant surface carcinogens
such as tobacco smoke and betel nut extracts (Weiss and
Goldblum, 2001). Generally, there is progression through increas-
ing grades of epithelial dysplasia to invasive malignancy. Although
tumours of the oral cavity usually present with relatively low-
volume disease compared with those of the oropharynx, cancers of
the buccal lining, the most common subgroup affecting Asian and
African communities, typically present at a late stage owing to the
relative insensitivity of this part of the mouth (Watkinson et al,
2000). In addition, treatment protocols involving surgery and/or
chemotherapy are disfiguring and associated with considerable
morbidity.
The nonspecific clinical appearances of dysplastic and early
malignant lesions in the oral cavity further emphasise the need to
develop effective methods for earlier detection of such lesions.
Unlike the larynx, where a similar pattern of neoplastic progres-
sion is observed and where the need for minimally invasive
approaches is arguably just as pressing (Chatrath et al, 2003), the
oral cavity is more easily accessible for tissue sampling, tumour
surveillance and post-treatment monitoring, without a require-
ment for expensive flexible nasoendoscopic equipment or
advanced expertise. Indeed, screening of the oral cavity using
LBC could conceivably be performed using a self-administered
mouthwash technique.
One of the features of epithelial dysplasia and malignancy is
ectopic cell cycle entry. As key proteins of the prereplication
complex, MCMs are sensitive and specific markers of cells in cycle.
Indeed, we have previously suggested that deregulated expression
of these proteins may characterise the dysplastic and malignant
states (Freeman et al, 1999). In studies of neoplastic lesions at
other anatomical sites, MCMs have consistently been more
abundant than other putative markers of cell cycle entry, such as
Ki67 (Gonzalez et al, 2005). Our present data is consistent with
such observations and suggests that MCMs are likely to be more
sensitive biomarkers for cytological diagnosis of oral malignancy
and dysplasia than Ki67.
Our cytological data are fully consistent with our histopatho-
logical observations and indicate that MCM-positive epithelial cells
are likely to be present in smears from oral SCC but not in scrapes
of mild dysplasia and benign keratosis. In the present study, we
did not test directly the value of MCM immunocytochemistry in
detecting severe/moderate oral dysplasia. However, the high
frequency of expression of Mcm-2 in surface layers in histological
sections of these conditions suggests that the detection sensitivity
in smears is likely to be very high. Taken together, our data
suggests that the value of MCM immunocytochemistry in the
analysis of oral smears is likely to be similar to that for other
cytological samples, such as smears of the cervix and larynx, where
detection of MCMs enables dysplastic and malignant cells to be
detected with a high degree of sensitivity and specificity (Williams
et al, 1998; Chatrath et al, 2003).
We have not investigated whether MCMs enable identification of
the approximately 20% of dysplastic oral lesions that progress to
SCC. The presence of gross genomic abnormalities, manifesting as
tetraploidy or aneuploidy, has been claimed to be a useful
indicator of lesions destined to progress (Lippman et al, 2005).
200 m 
100 m 
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B
Figure 4 MCM immunocytochemistry in oral smears. Squamous
epithelial cells from normal mucosa (A) are negative when stained with
antibodies against MCM 2/5. In sharp contrast, a cluster of cells from an oral
SCC (B) are strongly positive for MCM 2/5 and can be identified readily,
even at low magnification.
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genomic instability, leading to aberrations in DNA content. Cell
cycle markers may therefore be useful progression markers, either
independently or as surrogate indicators of gross genomic
imbalances. Indeed, it may be easier for routine diagnostic
laboratories to measure cell cycle markers than DNA indices. It
will be worth investigating the relationships between aneuploidy in
oral lesions and cell cycle dysregulation, as demonstrated by
ectopic expression of cell cycle markers. As well as indicators of
cell cycle ‘state’, such as MCMs, the latter should also include
markers of cell cycle progression such as geminin, which is present
only in the later stages of the cell cycle and provides an indication
of cell cycle ‘rate’ in clinical samples (Gonzalez et al, 2005).
While our findings using conventional oral smears are broadly
comparable to those obtained with LBC, the latter appears to
reduce substantially the frequency of inadequate samples. As well
as providing overall cost benefits, this would be an important
practical advantage in some settings, including the developing
world, where it may be difficult for individuals to reattend for
repeat investigations should an initial sample prove inadequate.
The strong nuclear signal provided by MCMs makes identification
of immunopositive cells straightforward and should facilitate the
development of approaches to automated analysis of immuno-
stained slides.
In summary, MCM immunocytochemistry holds great promise
as a minimally invasive test for early detection of oral malignancy
and dysplasia. The strong clinical performance and ready
interpretation of stained LBC samples makes MCMs particularly
strong markers for high-throughput screening of high-risk
patients. Indeed, the method may be applicable to the developing
world where the incidence of oro-pharyngeal SCC is high (Vokes
et al, 1993). In this regard, oral washings may yield adequate
numbers of cells from many early lesions and thereby permit self-
sampling. Larger scale studies of this promising approach,
including assessment of correlations with potential markers of
progression such as aneuploidy, are now warranted.
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